Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
A peer-reviewed study published earlier this March, for instance, found that prescription rates of semaglutide and tirzepatide started rising substantially toward the end of 2022, while rates of bariatric surgery began dramatically declining in 2023
injecting on the same day each week keeps medication levels stable in your body
Because GLP-1 agonist drugs delay emptying of food from the stomach, food can get backed up in the stomach, preventing transit into the intestines which can paralyze and weaken the stomach
This makes it a great option if youre budget-conscious but still want to see results